Torrey Pines Law Group's biotech patent attorneys and patent agents have decades of experience. Prior to becoming patent attorneys, our group leaders studied and investigated a multitude of biotechnologies including monoclonal antibody research and development, bioinformatics systems, in vitro diagnostics, and biological and biopharmaceutical drug research and development. In addition, our attorneys and regulatory advisors have had hands-on experience with bringing biotechnologies to market through the FDA regulatory process and related hurdles including clinical trials, investment funding, acquisitions, CMC, international supply and distribution, packaging, labeling, and licensing, among many other hurdles.
Our substantial real world experience has provided our clients valuable insight into solving complex legal problems related to:
Torrey Pines Law Group's clients are on the leading edge of biotechnology innovation. Those biotechnology innovations include technologies that affect our daily lives such as personalized medicine, CRISPR, RNAi (RNA interference), biosensors, in vitro diagnostics, and clinical diagnostics. We have also helped advance more controversial technologies including "pharming," regenerative medicine, embryonic stem cell research, pluripotent stem cells, and gene editing.
One can imagine that the entire body of biotechnology law that affects this patchwork of technologies is as varied and far-reaching as the underlying technologies themselves. Biotechnology law has become a continuously adaptive body of law that evolves with the pace of biotechnology development, and because biotechnology law is also influenced by business cycles and the market, the most effective way to understand biotechnology law is by studying its evolution at the intersection of law, business, and science. Legal issues at this intersection include intellectual property (especially patents), federal regulation, research funding, federal approval of products for human use, privacy issues, and international issues, among many other unique legal issues.
The IP attorneys, patent lawyers, engineers, scientists, and patent agents at Torrey Pines Law Group have also worked in a variety of biotechnology industries and have assisted with commercializing, researching, and developing technologies including:
We welcome the opportunity to provide you more detailed information about our firm and see how we can work together. Please contact us to schedule a free initial consultation, and follow us on Facebook, Twitter, and LinkedIn.
COPYRIGHT © , TORREY PINES LAW GROUP, PC. ALL RIGHTS RESERVED. | LEGAL NOTICES | SITE MAP | PAYMENTS | STANDARD FIRM CHARGES
Torrey Pines Law Group, PC serves technology innovators with protecting intellectual property, obtaining regulatory approvals and clearances, and making deals and closing technology transactions throughout the U.S., including in major technology hubs such as San Diego, San Francisco, Palo Alto, San Jose, Silicon Valley, Boston, Cambridge, Chicago, Minneapolis, Houston, Dallas, Atlanta, Denver, Seattle, Portland, Boulder, Orlando, the Research Triangle (Raleigh, Durham, and Chapel Hill), the Mid-Atlantic (New Jersey, New York, Philadelphia, Maryland, Virginia, and Washington, DC), Pittsburgh, Cleveland, Ann Arbor, and throughout Southern California in Los Angeles, Orange County, Irvine, Torrey Pines, Sorrento Valley, and La Jolla.
We have experience with international intellectual property, regulatory and transactional matters pending in Beijing, Shanghai, Shenzhen, and Guangzhou China; Tokyo, Japan; Berlin, Munich and Frankfurt Germany; Tel Aviv Israel; Mumbai, Bengaluru, and New Delhi India; London and Edinburgh United Kingdom; Vancouver, Toronto, Calgary and Montreal Canada; Dublin, Ireland; Cape Town, South Africa; Mexico City and Tijuana Mexico; Brussels, Belgium; Copenhagen, Denmark; Paris, France; Madrid and Barcelona Spain; Moscow, Russia; Santiago, Chile; Montevideo, Uruguay; Buenos Aires, Argentina; Sao Paulo and Rio de Janeiro Brazil; Seoul, South Korea; Taipei, Taiwan; Hong Kong; Hanoi, Vietnam; Bangkok, Thailand; Kuala Lumpur, Malaysia; Milan, Italy; Singapore; Sydney, Melbourne, Perth and Adelaide Australia; Auckland, New Zealand; Oslo, Norway; Stockholm, Sweden; Helsinki, Finland; Kiev, Ukraine; Budapest, Hungary; Vienna, Austria; Prague, Czechia; Geneva and Lausanne Switzerland; Bahrain; Doha, Qatar; Abu Dhabi and Dubai UAE; and Jeddah, Saudi Arabia.
Biotechnology Patent Attorneys - Biopharmaceutical Patent Preparation & Prosecution Lawyers - Biotech Intellectual Property Law Firm - Monoclonal Antibody and Nanobody IP - RNAi Lawyers - Vaccine Counsel - CRISPR law